Cargando…

Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?

PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and commun...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichler, Theresia, Rohrmoser, Amy, Letsch, Anne, Westphalen, C. Benedikt, Keilholz, Ulrich, Heinemann, Volker, Lamping, Mario, Jost, Philipp J., Riedmann, Kristina, Herschbach, Peter, Goerling, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892511/
https://www.ncbi.nlm.nih.gov/pubmed/32885314
http://dx.doi.org/10.1007/s00520-020-05692-7
_version_ 1783652861108813824
author Pichler, Theresia
Rohrmoser, Amy
Letsch, Anne
Westphalen, C. Benedikt
Keilholz, Ulrich
Heinemann, Volker
Lamping, Mario
Jost, Philipp J.
Riedmann, Kristina
Herschbach, Peter
Goerling, Ute
author_facet Pichler, Theresia
Rohrmoser, Amy
Letsch, Anne
Westphalen, C. Benedikt
Keilholz, Ulrich
Heinemann, Volker
Lamping, Mario
Jost, Philipp J.
Riedmann, Kristina
Herschbach, Peter
Goerling, Ute
author_sort Pichler, Theresia
collection PubMed
description PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and communication. To meet these challenges, healthcare professionals need to gain deeper insight into patients’ subjective experiences. Therefore, this qualitative study examined information aspects of MD programs in cancer patients. METHODS: In two German Comprehensive Cancer Centers, 30 cancer patients undergoing MD participated in semi-structured interviews on information transfer and information needs regarding MD. Additionally, patients provided sociodemographic and medical data and indicated their subjective level of information (visual analogue scale, VAS, 0–10). RESULTS: On average patients had high levels of information (mean = 7, median = 8); nevertheless 20% (n = 6) showed an information level below 5 points. Qualitative analysis revealed that patients show limited understanding of the complex background of MD and have uncertainties regarding their personal benefit. Further, patients described unmet information needs. Existential threat in awaiting the results was experienced as burdensome. To withstand the strains of their situation, patients emphasized the importance of trusting their physician. CONCLUSION: The challenges in PCM consist in providing unambiguous information, especially concerning treatment benefit, and providing guidance and support. Therefore, psycho-oncology needs to develop guidelines for adequate patient communication in order to help healthcare providers and cancer patients to handle these challenges in the developing field of PCM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05692-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7892511
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78925112021-03-03 Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine? Pichler, Theresia Rohrmoser, Amy Letsch, Anne Westphalen, C. Benedikt Keilholz, Ulrich Heinemann, Volker Lamping, Mario Jost, Philipp J. Riedmann, Kristina Herschbach, Peter Goerling, Ute Support Care Cancer Original Article PURPOSE: Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient information and communication. To meet these challenges, healthcare professionals need to gain deeper insight into patients’ subjective experiences. Therefore, this qualitative study examined information aspects of MD programs in cancer patients. METHODS: In two German Comprehensive Cancer Centers, 30 cancer patients undergoing MD participated in semi-structured interviews on information transfer and information needs regarding MD. Additionally, patients provided sociodemographic and medical data and indicated their subjective level of information (visual analogue scale, VAS, 0–10). RESULTS: On average patients had high levels of information (mean = 7, median = 8); nevertheless 20% (n = 6) showed an information level below 5 points. Qualitative analysis revealed that patients show limited understanding of the complex background of MD and have uncertainties regarding their personal benefit. Further, patients described unmet information needs. Existential threat in awaiting the results was experienced as burdensome. To withstand the strains of their situation, patients emphasized the importance of trusting their physician. CONCLUSION: The challenges in PCM consist in providing unambiguous information, especially concerning treatment benefit, and providing guidance and support. Therefore, psycho-oncology needs to develop guidelines for adequate patient communication in order to help healthcare providers and cancer patients to handle these challenges in the developing field of PCM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05692-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-09-03 2021 /pmc/articles/PMC7892511/ /pubmed/32885314 http://dx.doi.org/10.1007/s00520-020-05692-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Pichler, Theresia
Rohrmoser, Amy
Letsch, Anne
Westphalen, C. Benedikt
Keilholz, Ulrich
Heinemann, Volker
Lamping, Mario
Jost, Philipp J.
Riedmann, Kristina
Herschbach, Peter
Goerling, Ute
Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title_full Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title_fullStr Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title_full_unstemmed Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title_short Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
title_sort information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892511/
https://www.ncbi.nlm.nih.gov/pubmed/32885314
http://dx.doi.org/10.1007/s00520-020-05692-7
work_keys_str_mv AT pichlertheresia informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT rohrmoseramy informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT letschanne informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT westphalencbenedikt informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT keilholzulrich informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT heinemannvolker informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT lampingmario informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT jostphilippj informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT riedmannkristina informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT herschbachpeter informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine
AT goerlingute informationcommunicationandcancerpatientstrustinthephysicianwhatchallengesdowehavetofaceinaneraofprecisioncancermedicine